Q&A

Each cartridge contains 0.81 grams of medical cannabis from a raw cannabis inflorescence that underwent a structural change. In this groundbreaking technology, which is more advanced than evaporation and certainly more than smoking, the amount of active ingredients administrated in the course of the treatment with the SyqeAir Inhaler is measured by the dose of the active ingredients absorbed into the blood at the microgram level per milliliter, rather than the mass of the plant.

Syqe® purchases the cannabis from the Dutch company Bedrocan, that grows and markets quality cannabis grown under clinical conditions in adherence with controlled conditions (GMP). The uniqueness of their cannabis and the reason why we import cannabis from Bedrocan is that the concentration of active ingredients in the cannabis is uniform. And only through a uniform concentration, patients can be provided with a consistent dose and receive a uniform effect with each use (instead of having an intermittent effect).

As a Med-Tech company, we at Syqe® are determined to provide a uniform care to our patients. The tests we conducted showed that Bedrocan is the only cannabis company in the world at the moment that provides a chemically stable cannabis strain, free from contaminants and mold and grown without chemical pesticide.

Syqe® is not a cannabis company, but a Med-Tech company that developed groundbreaking technology for the delivery of a therapeutic solution by inhalation. We believe it is our responsibility to reduce the amount of pain and suffering in the world and are determined to find the medical, safe, effective, consistent, and most convenient way to use medical cannabis for treatment. The SyqeAir Inhaler sets a new medical standard: metered medical cannabis treatment through inhalation, supported by clinical trials that prove its efficacy and safety.